文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

细胞质钙:阿尔茨海默病及其他神经退行性疾病中的法官、陪审团和执行者。

Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond.

机构信息

Center for Neurodegenerative Disease and Therapeutics, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.

School of Graduate and Postdoctoral Studies, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USA.

出版信息

Alzheimers Dement. 2023 Aug;19(8):3701-3717. doi: 10.1002/alz.13065. Epub 2023 May 3.


DOI:10.1002/alz.13065
PMID:37132525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10490830/
Abstract

This review discusses the driving principles that may underlie neurodegeneration in dementia, represented most dominantly by Alzheimer's disease (AD). While a myriad of different disease risk factors contribute to AD, these ultimately converge to a common disease outcome. Based on decades of research, a picture emerges where upstream risk factors combine in a feedforward pathophysiological cycle, culminating in a rise of cytosolic calcium concentration ([Ca ] ) that triggers neurodegeneration. In this framework, positive AD risk factors entail conditions, characteristics, or lifestyles that initiate or accelerate self-reinforcing cycles of pathophysiology, whereas negative risk factors or therapeutic interventions, particularly those mitigating elevated [Ca ] , oppose these effects and therefore have neuroprotective potential.

摘要

这篇综述讨论了可能导致痴呆症中神经退行性变的驱动原则,以阿尔茨海默病(AD)最为突出。虽然有无数不同的疾病风险因素导致 AD,但这些因素最终都汇聚到一个共同的疾病结果上。基于数十年的研究,出现了这样一幅画面:上游风险因素在一个前馈病理生理循环中结合在一起,最终导致细胞溶质钙浓度([Ca 2+ ])升高,引发神经退行性变。在这个框架中,AD 的阳性风险因素涉及引发或加速自我强化病理生理循环的条件、特征或生活方式,而阴性风险因素或治疗干预措施,特别是那些减轻升高的[Ca 2+ ]的措施,会对抗这些效应,因此具有神经保护潜力。

相似文献

[1]
Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond.

Alzheimers Dement. 2023-8

[2]
Ubiquitin-proteasome system in the different stages of dominantly inherited Alzheimer's disease.

Alzheimers Dement. 2025-5

[3]
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Cochrane Database Syst Rev. 2017-3-22

[4]
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.

IEEE J Transl Eng Health Med. 2025-4-10

[5]
Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.

eNeuro. 2017-3-27

[6]
Acute targeting of N-terminal tau protein has long-lasting beneficial effects in Tg2576 APP/Aβ mouse model by reducing cognitive impairment, cerebral Aβ-amyloidosis, synaptic remodeling and microgliosis later in life.

Acta Neuropathol Commun. 2025-5-29

[7]
Impact of diabetes on the progression of Alzheimer's disease via trajectories of amyloid-tau-neurodegeneration (ATN) biomarkers.

J Nutr Health Aging. 2025-2

[8]
Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model.

Elife. 2024-1-29

[9]
Exploring the link between dystrophic microglia and the spread of Alzheimer's neuropathology.

Brain. 2025-1-7

[10]
Recent advances in the detection and management of motor dysfunction in Alzheimer's disease.

Psychiatriki. 2025-5-14

引用本文的文献

[1]
From a traditional medicine monomer to a modern neurotherapeutic scaffold: a review of SAR-Driven tetramethylpyrazine derivatives for cerebrovascular and cognitive health.

Front Pharmacol. 2025-8-21

[2]
The Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer's disease.

Arch Toxicol. 2025-9-1

[3]
Tauopathies: Calmodulin Regulates Tau Hyperphosphorylation and Its Transformation into Disease-Specific Aggregates.

Biomolecules. 2025-8-6

[4]
Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer's disease.

Inflammopharmacology. 2025-8-27

[5]
An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease.

Alzheimers Dement. 2025-8

[6]
Dysregulated calcium signaling in the aged primate association cortices: vulnerability to Alzheimer's disease neuropathology.

Front Aging Neurosci. 2025-7-15

[7]
Dysregulated calcium signaling in the aged macaque entorhinal cortex associated with tau hyperphosphorylation.

Front Aging Neurosci. 2025-4-29

[8]
The calmodulin hypothesis of neurodegenerative diseases: searching for a common cure.

Neurodegener Dis Manag. 2025

[9]
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.

Signal Transduct Target Ther. 2025-3-21

[10]
Cerebrospinal Fluid Calcium Balance in Tick-Borne Encephalitis: A Preliminary Study and Future Research Directions.

Biomedicines. 2025-2-2

本文引用的文献

[1]
Targeting ryanodine receptors to treat human diseases.

J Clin Invest. 2023-1-17

[2]
A Gating Mutation in Ryanodine Receptor Type 2 Rescues Phenotypes of Alzheimer's Disease Mouse Models by Upregulating Neuronal Autophagy.

J Neurosci. 2023-2-22

[3]
Protein mishandling and impaired lysosomal proteolysis generated through calcium dysregulation in Alzheimer's disease.

Proc Natl Acad Sci U S A. 2022-12-6

[4]
Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders.

Nat Rev Neurosci. 2023-1

[5]
Protein synthesis inhibition and loss of homeostatic functions in astrocytes from an Alzheimer's disease mouse model: a role for ER-mitochondria interaction.

Cell Death Dis. 2022-10-18

[6]
Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer's disease.

Cell Rep. 2022-8-23

[7]
Association of AK4 Protein From Stem Cell-Derived Neurons With Cognitive Reserve: An Autopsy Study.

Neurology. 2022-11-15

[8]
Mitophagy in Alzheimer's disease: Molecular defects and therapeutic approaches.

Mol Psychiatry. 2023-1

[9]
Faulty autolysosome acidification in Alzheimer's disease mouse models induces autophagic build-up of Aβ in neurons, yielding senile plaques.

Nat Neurosci. 2022-6

[10]
Axonal transport of late endosomes and amphisomes is selectively modulated by local Ca efflux and disrupted by PSEN1 loss of function.

Sci Adv. 2022-4-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索